Capricor Therapeutics Inc Share Price Today: Live Updates & Key Insights
Capricor Therapeutics Inc share price today is $29.45, up -6.64%. The stock opened at $31 against the previous close of $31.17, with an intraday high of $31.91 and low of $29.105.
Capricor Therapeutics Inc Share Price Chart
Capricor Therapeutics Inc
Capricor Therapeutics Inc Share Price Performance
Capricor Therapeutics Inc Institutional Holdings
Capricor Therapeutics Inc Market Status
Capricor Therapeutics Inc Fundamentals
Market Cap 1669.49 M
PB Ratio 5.4633
PE Ratio 0.0
Enterprise Value 1586.62 M
Total Assets 355.95 M
Volume 5760601
Capricor Therapeutics Inc Company Financials
About Capricor Therapeutics Inc & investment objective
Company Information Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The company also develops Exosome protein-based vaccine, which is in preclinical trial to treat SARS-CoV-2; StealthX Exosome Platform, and exosome platform program consists of engineered exosomes for vaccine and therapeutic development and is in preclinical trial. In addition, it engages in developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases; It has license agreement with Johns Hopkins University, University of Rome License, and Cedars-Sinai Medical Center to develop and commercialize licensed products and licensed services under the licensed patent rights in all fields and a nonexclusive right to the know-how; Cell Line License Agreement with Life Technologies for the development of exosomes platform. The company was founded in 2005 and is headquartered in San Diego, California.
Organisation Biotechnology
Employees 231
Industry Biotechnology
CEO Dr. Linda Marbán Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Capricor Therapeutics Inc FAQs
What is the share price of Capricor Therapeutics Inc today?
The current share price of Capricor Therapeutics Inc is $29.45.
Can I buy Capricor Therapeutics Inc shares in India?
Yes, Indian investors can buy Capricor Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Capricor Therapeutics Inc shares in India?
You can easily invest in Capricor Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Capricor Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Capricor Therapeutics Inc.
Can I buy fractional shares of Capricor Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Capricor Therapeutics Inc?
Capricor Therapeutics Inc has a market cap of $1669.49 M.
In which sector does Capricor Therapeutics Inc belong?
Capricor Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Capricor Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Capricor Therapeutics Inc?
The PE ratio of Capricor Therapeutics Inc is N/A and the PB ratio is 5.46.